Mutagen sensitivity as a predictor of tumor recurrence in patients with cancer of the upper aerodigestive tract.
Spitz
M R
MR
Department of Epidemiology, The University of Texas M. D. Anderson Cancer Center, Houston 77030, USA.
Lippman
S M
SM
Jiang
H
H
Lee
J J
JJ
Khuri
F
F
Hsu
T C
TC
Trizna
Z
Z
Schantz
S P
SP
Benner
S
S
Hong
W K
WK
D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000494:pharmacology*; D001761:Bleomycin / Q000494:pharmacology*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy* / Q000235:genetics*; D017326:Clinical Trials, Phase III as Topic; D005260:Female; D006258:Head and Neck Neoplasms / Q000188:drug therapy* / Q000235:genetics*; D006801:Humans; D015474:Isotretinoin / Q000494:pharmacology; D008297:Male; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D009153:Mutagens / Q000494:pharmacology*; D016016:Proportional Hazards Models; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D013723:Teratogens / Q000494:pharmacology; D017211:Treatment Failure
D000964:Antimetabolites, Antineoplastic; D009153:Mutagens; D013723:Teratogens; D001761:Bleomycin; D015474:Isotretinoin